Eleonora Rosati
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Clinical Vignette: Piperacillin/tazobactam-associated myoclonic status epilepticus in a patient with end-stage renal failure on hemodialysis.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: April 21, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.
Journal: JAMA neurology
Published: February 09, 2026
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage?
Journal: Expert review of clinical pharmacology
Published: July 05, 2025
A proposal for a machine-learning algorithm for the prediction of seizure recurrence risk at 2 years after discontinuation of anti-seizure medications.
Journal: Seizure
Published: June 24, 2025
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized Epilepsy.
Journal: JAMA network open
Published: March 10, 2025
Brain [18F]FDG-PET as a marker of disease activity in a case of CASPR2 limbic encephalitis.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 01, 2025
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis.
Journal: CNS drugs
Published: February 02, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study.
Journal: Neurology and therapy
Published: December 28, 2024
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).
Journal: Epilepsia open
Published: December 23, 2024
Last Updated: 09/26/2026